BUSINESS BRIEFING / PHARMACEUTICALS
- Share via
Times Wire Services
Seeking to cut costs and bring new drugs to market quicker as its bestsellers go off-patent, drug maker Eli Lilly & Co. plans to eliminate 5,500 jobs over two years and reorganize into five business units.
The Indianapolis company said it would reduce its workforce nearly 14%, to 35,000 from 40,500, by the end of 2011. Lilly hopes to cut annual costs by $1 billion over that period and will organize itself into cancer, diabetes, established markets, emerging markets and animal health units.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
